Metraipolis › archive › dc_7335f40b5368
Therapy optimization in metastatic colorectal cancer guided by discordant KRAS mutation status between primary and metachronous recurrent lesions: a precision… — Europe PMC PMID:42130526
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42130526
- DOI
- 10.1097/rc9.0000000000000382
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T16:04:15.201Z
- SHA-256 of the archived text
23e4ebf31ce41155fbe6a29fb4e47898ab1678f90be980d8bd70583b78e14ddc- Stable URL of this page
https://metraipolis.com/documento/dc_7335f40b5368
How to cite
Therapy optimization in metastatic colorectal cancer guided by discordant KRAS mutation status between primary and metachronous recurrent lesions: a precision… — Europe PMC PMID:42130526 — Europe PMC (en), https://europepmc.org/article/MED/42130526 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7335f40b5368 (Metraipolis archive dc_7335f40b5368, sha256 23e4ebf31ce41155fbe6a29fb4e47898ab1678f90be980d8bd70583b78e14ddc)
BibTeX
@misc{dc7335f40b5368,
title = {Therapy optimization in metastatic colorectal cancer guided by discordant KRAS mutation status between primary and metachronous recurrent lesions: a precision… — Europe PMC PMID:42130526},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42130526},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7335f40b5368; sha256 23e4ebf31ce41155fbe6a29fb4e47898ab1678f90be980d8bd70583b78e14ddc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42130526. Agents can read the archived copy with the MCP tool read_document.